Systematic Financial Management LP Has $1.39 Million Holdings in Hill-Rom Holdings, Inc. (HRC)

Share on StockTwits

Systematic Financial Management LP lessened its holdings in Hill-Rom Holdings, Inc. (NYSE:HRC) by 5.6% in the first quarter, Holdings Channel reports. The institutional investor owned 13,145 shares of the medical technology company’s stock after selling 780 shares during the period. Systematic Financial Management LP’s holdings in Hill-Rom were worth $1,392,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of HRC. Oregon Public Employees Retirement Fund raised its holdings in Hill-Rom by 8,755.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,308,056 shares of the medical technology company’s stock valued at $26,000 after buying an additional 2,281,991 shares during the last quarter. Norges Bank bought a new position in Hill-Rom in the 4th quarter valued at approximately $66,335,000. Bank of New York Mellon Corp raised its holdings in Hill-Rom by 27.0% in the 4th quarter. Bank of New York Mellon Corp now owns 1,038,521 shares of the medical technology company’s stock valued at $91,961,000 after buying an additional 220,981 shares during the last quarter. BlackRock Inc. raised its holdings in Hill-Rom by 3.5% in the 4th quarter. BlackRock Inc. now owns 6,350,899 shares of the medical technology company’s stock valued at $562,371,000 after buying an additional 215,770 shares during the last quarter. Finally, Two Sigma Investments LP raised its holdings in Hill-Rom by 260.1% in the 4th quarter. Two Sigma Investments LP now owns 255,055 shares of the medical technology company’s stock valued at $22,585,000 after buying an additional 184,230 shares during the last quarter. Institutional investors and hedge funds own 84.76% of the company’s stock.

Hill-Rom stock traded down $0.05 during mid-day trading on Friday, hitting $99.05. 1,187 shares of the stock were exchanged, compared to its average volume of 563,854. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.27 and a current ratio of 1.69. Hill-Rom Holdings, Inc. has a 12 month low of $81.82 and a 12 month high of $108.68. The firm has a market cap of $6.62 billion, a price-to-earnings ratio of 20.86, a PEG ratio of 1.69 and a beta of 0.91.

Hill-Rom (NYSE:HRC) last released its quarterly earnings results on Friday, April 26th. The medical technology company reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.03. Hill-Rom had a net margin of 7.93% and a return on equity of 21.30%. The firm had revenue of $714.20 million during the quarter, compared to analyst estimates of $705.59 million. During the same quarter last year, the business earned $1.05 EPS. The company’s revenue was up .5% compared to the same quarter last year. As a group, equities research analysts predict that Hill-Rom Holdings, Inc. will post 5.05 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 21st will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, June 20th. This represents a $0.84 annualized dividend and a yield of 0.85%. Hill-Rom’s payout ratio is 17.68%.

A number of brokerages recently issued reports on HRC. Zacks Investment Research lowered shares of Hill-Rom from a “hold” rating to a “sell” rating in a report on Friday, March 1st. Barclays raised their price objective on shares of Hill-Rom from $103.00 to $108.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Needham & Company LLC reiterated a “buy” rating and issued a $116.00 price objective on shares of Hill-Rom in a report on Monday, March 11th. Finally, ValuEngine upgraded shares of Hill-Rom from a “hold” rating to a “buy” rating in a report on Saturday, January 19th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $109.88.

ILLEGAL ACTIVITY WARNING: “Systematic Financial Management LP Has $1.39 Million Holdings in Hill-Rom Holdings, Inc. (HRC)” was posted by Macon Daily and is the property of of Macon Daily. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://macondaily.com/2019/05/17/systematic-financial-management-lp-has-1-39-million-holdings-in-hill-rom-holdings-inc-hrc.html.

Hill-Rom Profile

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Read More: What are municipal bonds?

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.